@article{8f713ac5a9264115865293827249cb02,
title = "Enterovirus D68: a test case for the use of immunological surveillance to develop tools to mitigate the pandemic potential of emerging pathogens",
author = "Hai Nguyen-Tran and Park, \{Sang Woo\} and Kevin Messacar and Dominguez, \{Samuel R.\} and Vogt, \{Matthew R.\} and Sallie Permar and Perdita Permaul and Michelle Hernandez and Douek, \{Daniel C.\} and McDermott, \{Adrian B.\} and Metcalf, \{C. Jessica E.\} and Bryan Grenfell and Spaulding, \{Alicen B.\}",
note = "Funding Information: SRD reports contracts from Biofire Diagnostics and Pfizer; consulting fees from Biofire Diagnostics, DiaSorin Molecular, and Karius, outside the submitted work. MRV reports grants from the US National Institute of Allergy and Infectious Disease, the Thrasher Research Fund, the Pediatric Infectious Diseases Society Foundation; consulting fees from IDBiologics and HDT Bio, outside the submitted work. MRV is also an inventor a pending international patent application on human monoclonal antibodies to enterovirus D68. SP reports contracts from Merck Vaccines and Moderna for institutional sponsored programmes, and consulting fees from Moderna, Merck, Dynavax, Pfizer, and HOOKIPA Biotech, outside the submitted work. All other authors declare no competing interests. HN-T and SWP contributed equally. ",
year = "2022",
month = feb,
doi = "10.1016/S2666-5247(21)00312-8",
language = "English (US)",
volume = "3",
pages = "e83--e85",
journal = "The Lancet Microbe",
issn = "2666-5247",
publisher = "Elsevier Ltd",
number = "2",
}